Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm
Objective: To describe the characteristics of patients with cervical dystonia (CD) or blepharospasm (BLEPH) treated with botulinum toxin (BoNT) in routine care using claims data…A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block
Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication
Objective: Report real-world safety of onabotulinumtoxinA used concomitantly for multiple therapeutic indications. Background: Therapeutic onabotulinumtoxinA is approved in the US for 12 indications, some of…Long term treatment with botulinum neurotoxin for focal dystonia – effect of dose and dilution
Objective: To evaluate the efficacy and safety of the higher dilution rates of Botulinum neurotoxin (BoNT) in focal dystonia. Background: BoNT is the first line…Diagnostic and treatment burden of dystonia in Turkey: a patient journey map
Objective: To assess the burden of access to diagnosis and botulinum neurotoxin (BoNT) treatment in Turkish patients with dystonia and hemifacial spasm (PwD/HFS). Background: Diagnostic…Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia
Objective: To assess the therapeutic outcomes of botulinum toxin injections (BoNT) in patients with lower limb dystonia (LLD). Background: BoNT to the affected muscle groups…A novel mobile application for monitoring the response to botulinum toxin in patients with Cervical Dystonia.
Objective: A pilot study to determine the acceptability of a novel DystoniaDiary application in patients with Cervical Dystonia (CD) attending a specialist clinic. Background: The…Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes
Objective: To investigate how patient reported outcomes (PROs) perform to document the effects of a botulinum neurotoxin (BONT) treatment of movement disorders in the clinical…Dystonia Treatment With Injections Supplemented by TMS: the D-TWIST Study
Objective: To evaluate the safety, feasibility, tolerability and effects of accelerated rTMS for treatment of cervical dystonia. Background: In a subgroup of patients with cervical…Incidence of dysphagia and comorbidities in patients with cervical dystonia, analyzed by botulinum neurotoxin treatment exposure
Objective: Describe real-world incidence of dysphagia and other comorbidities in adults with cervical dystonia (CD) treated and not treated with botulinum neurotoxin (BoNT). Background: Dysphagia…
- 1
- 2
- 3
- …
- 18
- Next Page »